MAT2A and central nervous system cancer: Considering the effects of the above targets on glioma, a series of small molecule inhibitors targeting the MAT2A–PRMT5 signal axis including a brain penetrating PRMT5-MTA inhibitor and MAT2A inhibitor [26] was recently and separately synthesized by our research group to test their effects when used alone or in combination.